Active	Status	Sponsor type	Region	Phase	Filter
10 Active 22 Inactive 32 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arrieta, Oscar
METLUNG, NCT05445791: Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations	Recruiting	3	312	RoW	Metformin Hydrochloride, Placebo	Instituto Nacional de Cancerologia de Mexico	Non Small Cell Lung Cancer	07/24	07/25
NCT03779191: Alectinib in Combination With Bevacizumab in ALK Positive NSCLC	Completed	2	41	RoW	Alectinib, Alecensa, Bevacizumab, Avastin	Instituto Nacional de Cancerologia de Mexico, Roche Pharma AG	ALK Gene Rearrangement Positive, Non-Squamous Non-Small Cell Neoplasm of Lung	08/22	10/22
NCT03803787: Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients	Recruiting	2	72	RoW	Inhaled budesonide, Numark	Instituto Nacional de Cancerologia de Mexico, Instituto Nacional de Enfermedades Respiratorias	Radiation Pneumonitis	12/24	12/24
NCT05713006: Alectinib Pharmacokinetic in Patients With NSCLC	Recruiting	1/2	45	RoW	Alectinib Oral Product, Alecensa 150 mg Roche	Instituto Nacional de Cancerologia de Mexico	Non-small Cell Lung Cancer Stage IIIB, ALK Gene Mutation	12/24	12/25
NCT02734069: Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC	Recruiting	N/A	132	RoW	Carboplatin, CARBOPLAT	Instituto Nacional de Cancerologia de Mexico	Lung Cancer, Sarcopenia, Toxicity	07/24	12/25
NCT02978521: Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients	Recruiting	N/A	94	RoW	Pulmonary rehabilitation	Instituto Nacional de Cancerologia de Mexico	Pulmonary Rehabilitation, Sarcopenia, Quality of Life	12/24	12/25
DETECTO, NCT06535451: Lung Cancer Screening Program in Mexico	Recruiting	N/A	1000	RoW	Screening	Instituto Nacional de Cancerologia de Mexico	Lung Cancer	03/26	03/27
NCT06238882: Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.	Recruiting	N/A	74	RoW	Nitroglycerin, Minitran® Patch	Instituto Nacional de Cancerologia de Mexico	Non-small Cell Lung Cancer, Brain Metastases, EGFR Gene Mutation	02/25	02/26
AEROBIKA, NCT05267496: Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery	Active, not recruiting	N/A	72	RoW	oscillating positive expiratory pressure device, AEROBIKA, Pulmonary rehabilitation	Instituto Nacional de Cancerologia de Mexico	Lung Cancer, Mediastinal Tumor, Pleural Tumor	02/23	12/23
STA-RR-LC, NCT06477302: Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer	Recruiting	N/A	281	RoW	Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)	Instituto Nacional de Cancerologia de Mexico	Lung Cancer	06/25	06/26